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LETTERS TO THE EDITORImplications of the 2014 updated American Heart
Association/American Stroke Association guidelines
for symptomatic carotid patients
The 2014 AmericanHeart Association/American Stroke Asso-
ciation (AHA/ASA) guidelines1 for symptomatic patients updated
the previous 2011 AHA/ASA recommendations.2 Because “these
Guidelines are addressed to all clinicians who manage secondary
prevention of stroke in symptomatic patients,”1 it is important to
analyze the expected implications of these recommendations.
Carotid endarterectomy (CEA) is once again recommended
for symptomatic patients with ipsilateral severe (70%-99%) or mod-
erate (50%-69%) carotid stenosis (Class I; Level of Evidence A and
B, respectively).1 Carotid artery stenting (CAS) is once again
“indicated as an alternative to CEA for symptomatic patients”1;
however, this is now a Class IIa (not a Class I)2 recommendation.1
Furthermore, a new recommendation was added suggesting that
“it is reasonable to consider patient age in choosing between
CAS and CEA.”1 CEA might be associated with improved out-
comes compared with CAS for patients >70 years, and for younger
patients the two procedures are equivalent (Class IIa; Level of Ev-
idence B).1
Several recommendations of the 20112 and the 2014 AHA/
ASA guidelines1 were largely based on the Carotid Revasculariza-
tion Endarterectomy vs Stent Trial (CREST).3 Results of CREST
were published on May 26, 20103 and was followed by three sub-
group analyses: one according to symptomatic status on February
9, 20114; one according to sex on May 5, 20115; and one accord-
ing to age on October 6, 2011.6 Because the 2011 AHA/ASA rec-
ommendations were published on October 21, 2010,2 they could
not have included the subsequent three CREST subgroup ana-
lyses.4-6 This limitation, however, does not apply to the 2014
AHA/ASA guidelines.1 Consequently, based on the CREST sub-
group analysis according to age,6 the 2014 AHA/ASA guidelines
made a new recommendation according to patient age.1 A similar
differentiation would be expected based on the results of the other
two CREST subgroup analyses.4,5 Such a differentiation, however,
was not made.
The CREST subgroup analysis according to symptomatic sta-
tus showed that symptomatic patients who underwent CAS had
nearly twofold greater periprocedural stroke and death rates
compared with CEA (6.0 6 0.9% vs 3.2 6 0.7%, respectively;
P ¼ .02).4 Because this subgroup analysis4 was completely omitted
in the 2014 AHA/ASA guidelines, it might explain why CAS is
still indicated as an alternative to CEA for symptomatic patients.1
Furthermore, although this is no longer a Class I,2 but a Class
IIa recommendation,1 the phrase used (ie, “CAS is indicated”) is
a phrase used for Class I recommendations (“should”, “is recom-
mended,” “is indicated,” or “is useful/effective/beneﬁcial”).1 The
suggested phrases for Class IIa recommendations are “is reason-
able,” “is probably recommended or indicated,” or “can be use-
ful/effective/beneﬁcial,” as is the case, eg, with age: “it is
reasonable to consider patient age.”.1 Although the Class of this
recommendation was revised, the recommendation itself remained
virtually the same.
In the abstract of the CREST subgroup analysis according to
sex, it is mentioned that “there was no signiﬁcant interaction in the
primary end point between sexes (interaction P ¼ .34).”5 This
information is replicated in the 2014 AHA/ASA guidelines.1
However, in the full CREST report it is mentioned that women
who underwent CAS had >2.5-fold greater periprocedural stroke
and stroke/death rates compared with women who underwent
CEA (hazard ratio, 2.63; P ¼ .013).5 It would therefore beexpected that besides patient age, the 2014 AHA/ASA guidelines1
would also differentiate their recommendations according to
patient sex.
The 2014 AHA/ASA guidelines1 is an inﬂuential document
that is expected to guide clinical practice not only in the United
States, but worldwide. The 2014 AHA/ASA guidelines1 have
revised and improved many of their previous recommendations2;
some of them, however, might still be misinterpreted. It is essential
to avoid any potential misinterpretations that could harm rather
than beneﬁt patients.
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Regarding “A simple technique to achieve bloodless
excision of carotid body tumors”
We read with great interest the article by Spinelli et al1 on “A
simple technique to achieve bloodless excision of carotid body
tumors,” who described the “double-clamping” technique for
Shamblin II-III carotid body tumor (CBT) resection to reduce837
